Biotech's new invaluable tool

In just two decades, the protein equivalent of an intron has carved out a significant niche in biotechnology -- and captured the interest of evolutionary biologists, who suspect these potentially ancient elements could provide clues to early enzymes. Image: Wikimedia commonsWith the ability to splice themselves out of proteins and paste the two loose ends of the protein back together, inteins are proving to be an invaluable tool in biotechnology. Just 20 years since their discovery, inteins are

Written byJef Akst
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share
In just two decades, the protein equivalent of an intron has carved out a significant niche in biotechnology -- and captured the interest of evolutionary biologists, who suspect these potentially ancient elements could provide clues to early enzymes.
Image: Wikimedia commons
With the ability to splice themselves out of proteins and paste the two loose ends of the protein back together, inteins are proving to be an invaluable tool in biotechnology. Just 20 years since their discovery, inteins are already being used to purify, manipulate, and even create proteins that were difficult (or impossible) to build using traditional techniques. "It's a very fast moving field," said chemical biologist linkurl:Fran Perler;http://www.neb.com/nebecomm/researchScientist.asp?id=FPerler of New England Biolabs, which currently has an intein-based purification method on the market. "The technology is all based on being able to introduce interesting chemical modifications into proteins and study how these modifications change the protein." The first intein was discovered in 1990 in the VMA1 gene of yeast, when researchers noticed that the gene, which codes for a membrane enzyme, appeared to be much larger than the polypeptide it produced. Upon closer examination of the nucleotide sequence, researchers noticed a segment in the middle of the gene that was missing from homologous genes. Further research revealed that the unusual sequence was excised before the final protein product, but unlike the well-known introns, the excision happened after the mRNA sequence had been translated into a protein. At the time, it was considered nothing more than "a molecular oddity," said molecular biologist linkurl:Xiang-Qin (Paul) Liu;http://www.biochem.dal.ca/faculty/facultypages/liu/ of Dalhousie University. But just two decades later, nearly 600 naturally occurring inteins have been found in all three domains of life, as well as in viruses, according to the InBase intein database, started by Perler. And while researchers are still trying to figure out what purpose they serve, if any, in the organisms that harbor them, more and more is being learned about how they work, and how they can best be put to use. "[Inteins have] many applications already realized in biotechnology and more and more emerging because it's a uniquely useful technology," Liu said. Specifically, it is the protein-splicing ability of the inteins that protein researchers find so useful. One way to take advantage of this quality, for example, is to insert a tag into or at the end of an intein, so that researchers can identify and separate the protein that contains the intein from solution. Once that's occurred, the intein can be activated to splice itself out, leaving only the mature protein behind. Indeed, systems based on this sort of technology are already commercially available. But inteins don't just cut; they also paste. In the late 1990s, Liu and his colleagues published the first example of split inteins, in which pieces of a gene are separated by some distance in the genome and come together by way of inteins that glue the pieces together as they splice themselves out. This so-called trans-splicing action generated excitement among protein biologists, who have used the technology to make synthetic proteins, or proteins with posttranslational modifications -- a feat that has linkurl:proven difficult;http://www.the-scientist.com/blog/display/56190/ using traditional protein synthesis methods. "[In] the current decade, we're realizing that DNA and that genomic information is only part of our hereditary information," Perler said. "There's all this epigenetic information [as well]. What [inteins] allow you to do is to synthesize proteins with these modifications and study the effect of these modifications both in vitro and in vivo. I think that's the most exciting application of inteins." In addition to their biotech applications, inteins have some unique characteristics that make them inherently interesting from an evolutionary perspective. Many inteins contain an endonuclease domain that allows them to jump between genomes. Indeed, phylogenetic analyses have suggested that they tend to be horizontally transmitted, with inteins at the same position in the same genes in different genomes showing high sequence similarity, "even if they're in different phyla," Perler said. Furthermore, many suspect that inteins are actually ancient elements that could perhaps provide some insight into some of the earliest enzymes. "Most of us that study inteins believe that the inteins we see now are remnants of the past," Perler said. It's possible, she explained, that the splicing domains initially existed without the endonucleases, which later "hijacked" the inteins by allowing them to jump to new genomic locations -- in other words, turning them into selfish DNA. Indeed, some inteins lack an endonuclease domain, and with a structure that suggests a duplication of two 65-amino acid domains -- the size of the first enzymes found in the primordial soup -- "inteins may have been involved in putting together protein domains," Perler said. "If you're trying to early in evolution figure out how to make better enzymes and better proteins, if these inteins allowed you to shuffle sequences, then it would be a really efficient way of building bigger proteins." Some also still wonder what function inteins might serve. "It's a really fascinating biological phenomenon, how selfish elements like this evolve," said microbiologist linkurl:Rahul Raghavan;http://www.biochem.arizona.edu/ochman/Personnel/raghavan.htm of Yale University. In the meantime, the evolving applications continue to drive the field, Perler said. With several technologies already on the market, and plenty more in the works, inteins are earning respect as a go-to technique in the protein toolbox. "The intein is not really the big deal," Perler said; "it's what you can do with it."
**__Related stories:__***linkurl:Science paper pulled;http://www.the-scientist.com/blog/display/56190/
[30th November 2009]*linkurl:Sweet Attachments;http://www.the-scientist.com/article/display/54587/
[May 2008]*linkurl:Off-the-shelf glycoprotein detection methods;http://www.the-scientist.com/article/display/54593/
[May 2008]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform